Cognitive Behavioral Therapy for Premature Infants' Families
(PreVNT Trial)
Trial Summary
What is the purpose of this trial?
This study is being done to see if outcomes for both a premature infant's parents and the infant born prematurely who have spent time in the neonatal intensive care unit (NICU) can be improved through parent cognitive behavioral therapy (CBT) sessions.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Parent Cognitive Behavioral Therapy for families of premature infants?
Research shows that brief cognitive-behavioral interventions can help reduce depressive symptoms in mothers of premature infants after hospital discharge. Additionally, educational-behavioral programs like COPE have been effective in improving parent mental health outcomes and enhancing parent-infant interactions.12345
Is Cognitive Behavioral Therapy safe for parents of premature infants?
How does Parent Cognitive Behavioral Therapy differ from other treatments for families of premature infants?
Parent Cognitive Behavioral Therapy is unique because it focuses on helping parents of premature infants manage stress, anxiety, and depression by changing negative thoughts and behaviors. Unlike other treatments, it specifically targets the psychological impact of having a premature infant, aiming to reduce symptoms of posttraumatic stress and improve mental health.12456
Research Team
Richard J Shaw, MD
Principal Investigator
Stanford University
Margaret K Hoge, MD
Principal Investigator
UT Southwestern Medical Center Dallas
Roy Heyne, MD
Principal Investigator
UT Southwestern Medical Center Dallas
Eligibility Criteria
This trial is for parents of premature infants born at <=30.6 weeks gestation and have survived to 33 weeks, who spent time in the NICU at Parkland Hospital. Parents must speak English or Spanish. It's not for those with CPS involvement or whose babies have significant congenital anomalies.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Parents receive 5 CBT sessions to address PPCV and VCS, with 3 sessions in the NICU and 2 sessions post-discharge
Follow-up
Participants are monitored for changes in parental perceptions and child development outcomes
Long-term follow-up
Evaluation of long-term outcomes for parents and children post-NICU discharge
Treatment Details
Interventions
- Parent Cognitive Behavioral Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor
Stanford University
Collaborator